Hair loss has become a widespread occurrence due to a number of factors, including stress and poor nutritional choices. Nonetheless, the underlying reason of balding has long been identified, and experts believe that this cell discovery may help them identify a treatment for baldness. Manchester University researchers have found that hair follicles may diet and become inactive due to metabolic stress. Baldness and hair loss are the long-term consequences of this. According to experts, in this instance, the body’s integrated stress response may slow down normal functions, such as hair development, when the body is infected or isn’t getting enough nutrients.
Researchers found that the process might go wrong and permanently destroy scalp cells when studying follicles in the lab. Balding can be significantly slowed by using medication to inhibit this process. Numerous hair loss conditions, including pattern baldness, have been linked to this reaction. This may lessen the long-term risk of untreated baldness, according to researchers.
Though it is unlikely that balding may be totally stopped, those who have lost all of their hair may be able to grow it back. It is feasible to halt the process for those who are truly losing it, though. Experts said that in this instance, the next course of action would be to devise a means of controlling the same. Men and women are likely to experience hair loss and pattern baldness by the age of 50, and women by the age of 70.
There are more factors besides age and lifestyle that contribute to hair loss. According to medical professionals, diseases like psoriasis and lupus, as well as side effects from medications, may be related to the same. Experts claim that this discovery was unintentionally made while researching the detrimental effects of medications on hair follicles. The stress response that is subsequently set off when hair follicles are unable to sprout can stop the growth of new hair. Experts were taken aback by how consistently different people responded. The findings of the same study were released in the Plos One journal, and patients undergoing chemotherapy or scarring alopecia may benefit from this discovery.